Expert record review should come before repeating invasive tests
PACNS is a diagnosis with important mimics, and many international patients already have several scans and lumbar punctures. A specialist review of DICOM imaging, angiography and complete laboratory data may identify which evidence is still missing. This can prevent automatic repetition of expensive or invasive procedures simply because only summary reports were submitted.
MRI cost depends on whether the existing protocol answers the vasculitis question
A useful work-up may require diffusion, FLAIR, susceptibility-sensitive and contrast-enhanced sequences, with vascular or vessel-wall imaging when clinically justified. If recent high-quality MRI already exists, the center may review it rather than repeat the study. A cost estimate should distinguish image review from new MRI and additional vascular imaging.
Lumbar puncture can involve more than routine cell count and protein
CSF is useful partly because infection, malignancy and other inflammatory disorders can mimic PACNS. Depending on the presentation, the laboratory work may extend to microbiology, virology, cytology, flow cytometry or additional immune testing. These tests are not interchangeable and should be ordered for a defined differential-diagnosis question.
Catheter angiography is a separate invasive diagnostic episode
Digital-subtraction angiography may be requested when non-invasive vascular imaging is insufficient or when the vascular pattern will change diagnostic confidence or management. Its cost can include the angiography suite, contrast, specialist fees, monitoring and observation. Not every suspected small-vessel PACNS case benefits from angiography, so it should not be budgeted as an automatic step for everyone.
Brain or meningeal biopsy can become the largest diagnostic cost component
When tissue diagnosis is needed, cost may include neurosurgical planning, image guidance, anaesthesia, pathology, neuropathology and inpatient observation. Because biopsy can be nondiagnostic if disease is patchy, the decision should be based on expected diagnostic value, ideally after imaging review and multidisciplinary discussion rather than as a routine package item.
Excluding mimics can broaden laboratory and specialty costs
Secondary vasculitis, infection, malignancy, systemic inflammatory disease, RCVS and other stroke mechanisms may require targeted laboratory testing or review by rheumatology, infectious diseases, neuroradiology, neuropathology or other specialties. The breadth of this work-up depends on the patient's presentation and previous testing, so two patients referred with the same 'PACNS' label can have very different diagnostic bills.
Immunosuppressive treatment cost depends on induction, monitoring and complications
Glucocorticoids are commonly used for induction, while selected patients receive an additional immunosuppressive agent. Cost therefore depends on whether treatment is oral or intravenous, outpatient or inpatient, whether infection screening and prophylaxis are required, laboratory monitoring, adverse effects and whether relapse or severe neurological disability prolongs care. A medication list alone is not enough to estimate the total episode.
Maintenance and follow-up are separate from the initial diagnostic trip
PACNS management can require follow-up neurology visits, repeat MRI or vascular imaging, tapering and monitoring of immunosuppression and reassessment for relapse. International patients should ask which follow-up can be performed locally and which investigations the German center expects to review remotely or on a return visit.
International self-pay quotes follow medical review
UKE's international workflow obtains medical records, forwards the case to the responsible department for a treatment plan and then prepares a cost estimate. Heidelberg likewise asks for medical information before its international office can calculate an individualized estimate. For a diagnostically uncertain disease such as PACNS, this sequence is particularly important because a quote issued before specialist review would not know whether angiography, biopsy or inpatient immunotherapy is actually required.
Send these records before asking for a PACNS cost estimate
A center can quote more realistically when it knows which diagnostic questions remain unresolved.
- Brain MRI DICOM files and reports
- MRA or CTA source images
- Catheter angiography / DSA images if already performed
- CSF laboratory results
- Autoimmune, inflammatory and infectious laboratory results
- Stroke/TIA and neurological symptom timeline
- Cardiac and vascular stroke work-up
- Any vessel-wall MRI or biopsy results
- Current and previous immunosuppressive drugs and response
- Requested service: diagnosis confirmation, differential diagnosis, angiography, biopsy review/planning, induction treatment, maintenance review or relapse assessment
Official sources
Last source-reviewed 2026-09-02. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.
- UKE international-patient workflow — University Medical Center Hamburg-Eppendorf (UKE) ↗
- UKE vascular outpatient clinic – cerebral vasculitis — University Medical Center Hamburg-Eppendorf (UKE) ↗
- Heidelberg international treatment inquiry — Heidelberg University Hospital ↗
- Heidelberg finance and individualized cost estimate — Heidelberg University Hospital ↗
- European Stroke Organisation PACNS guideline — European Stroke Journal / European Stroke Organisation ↗